Dolutegravir/Emtricitabine/Tenofovir Disoproxil Fumarate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dolutegravir/Emtricitabine/Tenofovir Disoproxil Fumarate, covering 2023-03-15 to 2023-03-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults [Phase 3]